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Abstract
Background: Precautionary ‘may contain’ warnings are used to indicate possible allergen contamination. Neither
food safety nor foods labelling legislation address this issue. The aim of this study is to understand how peanut
and nut allergic adults interpret ‘may contain’ labelling and how they use this information when purchasing food.
Methods: Qualitative methods were used to explore both behaviour and attitudes. The behaviour and ‘thinking
aloud’ of 32 participants were recorded during their normal food shop. A semi-structured interview also explored
participants’ views about 13 potentially problematic packaged foods. Transcribed data from these tasks were
analysed to explore the interpretation of ‘may contain’ labelling and how this influenced food choice decisions.
Results: Peanut and nut allergic individuals adopt a complex range of responses and strategies to interpret ‘may
contain’ labelling. Many claimed such labelling was not credible or desirable; many ignored it whilst some found it
helpful and avoided products with all such labelling. Interpretation and consequent decisions were not only based
on the detail of the labelling but also on external factors such as the nature of the product, the perceived
trustworthiness of the producer and on the previous experience of the nut allergic individual.
Conclusions: ’May contain’ labelling was interpreted in the light of judgements about the product, producer and
previous personal experience. It is vital that these interpretation strategies are taken into account by those
responsible for labelling itself and for the provision of advice to nut allergic individuals. Suggestions to improve
labelling and advice to the allergic individual are considered.
Background
Approximately 1% of North American and UK populations
are allergic to peanuts and other nuts [1-3] and these foods
cause the most frequent severe and fatal food associated
reactions [4-6]. At present, peanut or tree nut allergy (from
now, jointly referred to as ‘nut allergy’) cannot be treated
and management involves avoidance of nuts and emer-
gency treatment of reactions; the aim being to reduce
morbidity, mortality and improve an allergic individual’s
quality of life [7-9].
Consumers face complex food choices on a daily basis.
Most consumers balance a number of issues when
considering which foods to eat, including the price, taste
and whether the food is nutritious [10,11]. Food allergic
individuals additionally need to avoid allergens to pre-
vent potentially life threatening reactions. Packet infor-
mation is vital in assisting with such decisions.
To help nut allergic consumers avoid products that con-
tain nuts, there are several sources of information on food
packaging. These include the product name, ingredients
list, allergy (‘contains’) advice and precautionary (‘may
contain’) information. If there is a possibility that a food
may contain traces of an allergenic food, not as an inten-
tional ingredient, but as a result of cross-contamination
through, for example, shared manufacturing equipment,
this risk is often indicated by a precautionary ‘may contain’
type label (e.g. ‘may contain traces of peanut’). Such pre-
cautionary statements are not covered in either food safety
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or food labelling legislation [12]. In a U.S. supermarket
survey of over 20,000 products [13], 17% of products had
precautionary allergen labelling. In a study from 10
European countries of over 500 types of biscuits and cho-
colate, ‘may contain’ type labelling was included on the
packaging of 26% of biscuits and 80% of chocolate. In
addition 31% of the biscuit labels referred to the possible
presence of allergens in the production environment and
6% of the chocolate labels did so [14].
There is considerable variety in the actual wording
used in may contain labelling (MCL) [15]. The aforemen-
tioned supermarket survey [13] noted 25 different var-
iants of MCL in use. The amount of nuts may be more
or less specified (e.g. ‘nuts’ or ‘traces of nuts’) and the
type of nuts may be more or less specified (e.g. ‘nuts’,
‘peanuts’ or ‘hazelnuts’ etc.). ‘May contain’ messages may
also be implied through alternative wording such as
‘cannot guarantee nut free’. It may also refer to character-
istics of the food production situation e.g. ‘produced on a
line which also handles nuts’.
The prevalence and variation of precautionary labelling,
although intended to assist the consumer in their food
choices, is increasingly considered as problematic for
food allergic consumers. Expert advice in this area [16] is
that consumers should always take seriously any ‘may
contain’ warnings on the label unless they have been
advised otherwise by their allergy consultant. The litera-
ture suggests that making decisions on the basis of MCLs
is problematic in several ways.
Firstly, foods that carry precautionary labels may actu-
ally be safe to eat and therefore consumers may be
following unnecessarily restrictive diets by heeding the
warning labels [17]. It is likely that 90% of products
with cautionary labels will contain no residues of peanut
protein, and some of those that do are at levels unlikely
to cause a clinical reaction [17].
Secondly, consumers are aware of the proliferation of
these warnings and, in the absence of a previous allergic
reaction to foods labelled in this way they may exercise
less caution with foods containing precautionary label-
ling, with a consequent risk of reaction [18]. A recent
study of allergic individuals and their parents reported
that 8% of those with accidental reactions attributed it to
having ignored a precautionary label [19]. Thirdly, the
variation in wording used by different manufacturers for
these precautionary labels, although not intended to con-
vey different degrees of risk, is often interpreted by the
consumer as doing so [20,21]. A survey of parents of nut
allergic patients reported that products labelled ‘not sui-
table for nut allergy sufferers’ or ‘may contain nuts’ were
more likely to be avoided than those stating ‘may contain
traces of nuts’ or ‘cannot guarantee this is nut free’ [22].
Previous research that has explored consumer reactions
to MCL and identified these issues is almost entirely
quantitative. This has been helpful both in characterising
consumer responses to MCL, and in indicating the preva-
lence of these responses. However, qualitative work is
able to provide unique insights into the complex reason-
ing processes that underlie such responses [23]. Accord-
ingly the present study builds on qualitative work that
explores MCL with adolescents and the parents of aller-
gic children [24,25] by focusing on the responses of
adults with nut allergies. Importantly, the qualitative
methods used in this study allow a focus on responses to
MCLs in actual shopping situations and in relation to
particular products. The chosen combination of methods
thus provided the opportunity to explore the research
questions in full recognition of the situational and con-
textual nature of food choice behaviours.
The aim of this study was to explore the food choice
decisions made when nut allergic adults are faced with
‘may contain’ labelling and the way in which they make
sense of such labelling.
Methods
Study population
Thirty two participants aged 16 or over with a clinical his-
tory compatible with IgE-mediated reactions to peanuts
and/or tree nuts were recruited to the study. Participants
were recruited via letter or email from three sources in the
UK: (1) specialist allergy clinics at Southampton University
Hospital Trust (SUHT), (2) from one of three primary care
settings or (3) from staff and students of the University of
Surrey who had received medical care from a mixture of
primary, secondary and tertiary care. Potential participants
completed a postal screening questionnaire. With the
exception of oral allergy syndrome to fruits and/or vegeta-
bles (as this would not affect the purchase of labelled pro-
ducts), individuals with allergies or intolerance to foods
other than peanut or tree nuts were not admitted to the
study. A further 22 participants were eligible to take part
in the study but did not wish to (a response rate of 59.3%).
Using a classification previously used for peanut allergy
[26], participants were classified by an allergen consultant
(JSL) in relation to the severity of their worst ever reaction
to nuts (severe, moderate or mild). The study was
approved by the National Research Ethics Service and
University of Surrey Ethics Committee.
Participants took part in three tasks: an accompanied
shop, followed by an interview which also included a pro-
duct choice reasoning task. This triangulation of methods
was undertaken in order to “reveal the different dimensions
of a phenomenon and to enrich understandings of the
multi-faceted, complex nature of the social world” [27].
Accompanied shop
Participants were firstly trained in a ‘think aloud’ metho-
dology [28,29] and then observed during their normal
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food shopping trip [30-32]. Whilst shopping, partici-
pants were asked to talk aloud at all times about what
they were thinking with regard to their food choices.
The researcher used prompts such as “what are you
thinking now?” and did not enter into conversation with
the participant during the shop. Important behaviours
and comments made by the participant were followed
up in the interview.
Semi-structured interview
Following the accompanied shop, an in-depth semi-
structured interview was carried out in the participant’s
home. The first part of the interview sought participant
reflections on the accompanied shop. The interview
schedule explored various aspects of living with nut
allergy such as diagnosis, symptoms, management of nut
allergy before focusing on their views about product
labelling in general and MCL in particular.
Product Choice Reasoning Task (PCRT)
As part of the interview, before being asked about labelling,
participants took part in the PCRT. They were shown 13
food products believed to pose potential dilemmas for nut
allergic consumers. Some of these dilemmas related to ‘may
contain’ type labelling. Products were assigned by an allergy
dietician as belonging to product categories that would gen-
erally be designated as high or low risk to nut allergic con-
sumers independently of what information was presented
on the label. There were ‘may contain’ type warnings on 6
of the PCRT products. Participants were asked if they
would eat each food item and were asked to identify the
factors that led them to make these decisions and the sorts
of dilemmas they may have experienced in doing this.
Details of the products used in the PCRT can be found in
Barnett et al. [12] and a full description of all the methods
and their protocols can be found in Barnett et al. [33].
Analysis
All parts of the study were recorded and fully transcribed.
This provided a rich and detailed corpus of data for ana-
lysis. The transcripts were coded by two researchers
using NVivo qualitative data analysis software [34].
Established techniques of thematic coding [35] were used
to capture the key points, positions and opinions that
were expressed. Areas of both consensus and difference
were identified in order to assist with characterising and
interpreting each theme. The developing interpretations
were regularly revisited by the researchers responsible for
the analysis on a day to day basis (JB, JL and KM) and
these were checked with the broader research team in
order to confirm the validity of the interpretations that
were being developed. This team included a clinician
(JSL) and the project advisor who has a severe nut allergy
(MHG).
Quotes are used below to illustrate the analytic points
being made and the participants who provided each quote
are identified in relation to which method the quote was
produced (AS = accompanied shop, I = interview, PCRT =
product choice reasoning task) their gender (F = female,
M = male) and severity of allergy (Severe, Moderate or
Mild). Where the quote includes an utterance by the
Interviewer this is indicated using I for Interviewer and P
for Participant.
Results
Study participants
Thirty two respondents were eligible and consented to par-
ticipate within the time-frame of the study (9 male; age
range 16-70 years). Twenty two participants were recruited
from SUHT specialist allergy clinics, 4 from primary care
settings and 6 from University staff and students. Eighteen
participants described previous severe reactions, 12 moder-
ate and 2 mild. Five participants had peanut allergy, 9 tree
nut allergy and 18 had both peanut and tree nut allergies.
On average, participants had had a diagnosed nut allergy
for 20 years (range 1- 63 years). Twenty two reported suf-
fering from a reaction within the last 2 years.
Evaluating and using ‘may contain’ labelling
Firstly we will outline participant evaluations, both posi-
tive and negative, of MCL. Secondly, we consider how
participants used MCL to decide whether to purchase
particular foods.
1. Evaluations of ‘may contain’ labelling
MCL was generally considered preferable when com-
pared to receiving no information regarding the possibi-
lity of risk. However, there was extensive evidence that
participants discounted the ‘may contain’ message in a
range of ways. The view that MCL was neither credible
nor desirable was frequently expressed.
MCL was seen to be important when the food product
was considered potentially risky. Under these circum-
stances the uncertainty of having no information about
potential cross contamination was viewed as unsatisfactory.
Even in...even in places like (coffee shop), there’s a lit-
tle note on the sign that says, “This contains nuts,”
tick. There’s not even that in the (supermarket) bakery
section. So it would help to have something which says
“This may contain nut traces”, even though I hate it
when it says “may contain”. Even that would be better
than nothing. (I, M, Severe)
MCL was also seen as positive when compared with
the lack of nut warnings evident on foreign products.
But they must be a comfort because that’s why I feel
nervous about the foreign packaging that doesn’t
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have anything. So even though they might, you know,
consciously, you might not really think they’re much
use, but subconsciously, they’re giving you some kind
of support. They’re like a comfort to you. You feel
like, oh, people are checking my food (I, F, Moderate)
MCL may be seen to provide reassurance as it conveys
the message that the nut content of food products has
been assessed and attended to by the manufacturer.
Most participants however claimed that the ‘may con-
tain’ message was not a helpful one. There were 4 main
ways in which participants discounted the ‘may contain’
message. First, some considered that it was not possible to
avoid all products with MCL and that doing so would
result in an unfeasibly limited diet.
I’ve now become sort of blasé in the millions of things
that say because if I didn’t eat things that said “may
contain traces of nuts” I’d have a very narrow spec-
trum of food that I could eat (I, M, Severe)
They therefore discounted the ‘may contain’ message
for pragmatic reasons.
Secondly, other participants felt that the motivations of
the message source (manufacturers or retailers) are sus-
pect and thus that the message is not to be trusted. The
main motivation imputed to such sources was that they
were simply trying to avoid any liability should any
adverse reactions occur.
I can understand why (the ‘may contain’ messages)
are there, because it’s a backside-covering exercise for
the manufacturers, because they can say “Well we put
it may contain traces of nuts in it, and he died, so it’s
not our fault”. So I can see why they’ve done it, but it’s
the over-usage of it - it’s the boy who cried wolf syn-
drome. After a while you just become blasé to it and
you just go, “well I’m going to eat it anyway”. (I, M,
Severe)
If it says “may”, I generally trust it and I generally
buy it, but ...That’s how they cover themselves in the
manufacturing process isn’t it? (AS, M, Severe)
Interestingly in the second quote above the participant
equates trusting MCL with the notion that there is noth-
ing in the product that he should be concerned about. The
impact of trust is complex. In the quote below the partici-
pant explains that he is disregarding the MCL as, if there
really were traces of nuts, the supermarket he shopped in
and trusted would warn about this more clearly.
Right... Now, I’d usually be a bit cautious with this
kind of stuff, but, being (supermarket name), I actually
trust them quite a lot because they’ll probably have a
breakdown...[on everything they make]. Oh, it says
“May contain traces of nuts” but...I think that actu-
ally...they’re probably just writing that and actually
they... Plus, I have had cookies from (supermarket
name) before, so I usually know they’re fine. I think
actually they would go further - if there was a genuine
risk of having nuts in, they would go further than say-
ing ‘May contain nut traces.’... (AS, M, Moderate)
Thus his trust in the supermarket, along with his
experience of the brand, allowed him to discount the
veracity of the ‘may contain’ warning. In the following
quote, as the company is trusted, this is taken to mean
that where they do label with ‘may contain’ the inference
that there is a real risk is warranted.
I don’t know why - I do tend to trust the company if
it doesn’t put “May contain traces of nut”, because so
many companies, like (brand name) just chuck that
on all their labels, and it makes me then wary of eat-
ing it because it says “May contain”. (I, F, Mild)
Thirdly, participants also attributed different levels of
risk to different variants of MCL and considered that dif-
ferent wordings of ‘may contain’ justified different avoid-
ance strategies: paying attention to the ‘stronger’ variant of
MCL provided grounds for dismissing the ‘weaker’ ver-
sion. The first quote below illustrates how ‘may contain
nuts’ was taken more seriously than ‘may contain traces of
nut’ and in the second quote mention of a specific nut was
considered to signal a greater risk.
May contain nuts” is...well, I wouldn’t eat it, because
that means it could contain nuts. “May contain traces
of nuts” is different. (I, F, Moderate)
If it says “May contain traces”, I’m okay with that -
I’ll buy that. But if it says quite specifically “May
contain traces of peanut”, then I won’t buy it,
because I think that’s the... I feel like - I don’t feel so
confident I think, because I think that’s a little bit
too specific, you know? (I, F, Severe)
More specific warnings are read as indicating that
there is some particular knowledge about the increased
risk of the presence of allergens and participants were
more likely to be inclined to take precautionary action
accordingly.
Finally there was evidence that nut allergic individuals
discounted MCL when they considered them to be
implausible. We identified two types of ‘implausible dis-
counting’: where ‘may contain’ was located on products
that legitimately contained nuts and on products where
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it was considered impossible that they would contain
nuts.
Well, I mean, when you look at...if you look at a
packet of peanuts and it says “This product may con-
tain traces of nuts,” it just...the whole thing becomes a
joke, doesn’t it? That’s just silly. You can’t put on a
packet of nuts “May contain nuts”. It’s a packet of
nuts! You know, if you’re going to put that, it just...it
seems like another tick-box exercise to reach a stan-
dard. It’s not actually commonsense. (I, F, Moderate)
Well, I just think it’s a bit stupid because may con-
tain...well, “ingredients - cannot guarantee...” for like
a bottle of lemonade or cherryade or something, is
like ludicrous. And they know...they know it’s pretty
much going to be fine. Yeah, you do kind of ignore
them, because you think, if they’re just saying that
about ingredients on lemonade, maybe that’s just
going to be the same on ingredients of like a sand-
wich or something. (I, F, Moderate)
Interestingly the second quote above suggests that the
participant uses the extreme case of flawed MCL to war-
rant the claim that other products with a much greater
likelihood of containing nuts, are not going to be proble-
matic. This extreme form of labelling was considered
particularly damaging by people with severe allergies for
whom ingesting allergens was particularly dangerous and
who consequently endeavoured to take MCL seriously. In
such situations adding highly implausible ‘may contain’
warnings was seen as adding insult to injury to people
who could not afford to discount them.
2. Using ‘may contain’ labelling
There was a broad range of behavioural responses to
MCL. A minority of participants said they would always
avoid foods labelled with ‘may contain’. The majority of
participants were at the other extreme and ignored ‘may
contain’ labelling when making a decision to purchase a
product. Sometimes participants adopted more differen-
tiated approaches.
Avoiding food with ‘may contain’ labelling Three par-
ticipants were clear in their claims that they avoided, and
would not eat, products labelled with any variants of ‘may
contain’. Any indication that nuts could be present led to
categorical avoidance of the product.
To me, if it says “may contain”, it means that that
person who’s produced it isn’t sure, and if that person
isn’t sure and cannot guarantee that it is, then I’m not
going to take that chance, simple as that (I, M, Severe)
MCL was sometimes linked to anxiety. One younger
participant described his lack of confidence in dealing
with ‘may contain’ labelling which had resulted in him
being too nervous to try new products since moving
away from home. He felt that this had constrained his
diet to such an extent that he was no longer eating a
balanced diet.
“I hate it when it says “May contain nut traces”
because that sentence comes up on pretty much every
product, food product. ... I can’t walk up to something
new and think..... that will be fine, because there’s a
notice on it which says “May contain nut traces.” So
that limits what I can try, .. so it’s hard to try new
things....it’s very difficult for me, as an individual, to
know what to do basically, you know, how to go
about trying new things”.
So far, I have to admit, I just haven’t tried new things.
So far, I’ve stuck to chocolate muffins, which I can eat,
fruit and veg, which is an obvious no nuts, and my
parents made me ready-made meals, but I probably
go for ready-made meals as well, and just the basics,
literally the basics, but I need to obviously expand a
bit if I want to...be able to feed myself properly (I, F,
Severe).
Sometimes avoidance was linked to having had a reac-
tion to food labelled with a ‘may contain’ warning. The
fact that they had had a reaction to such products made
some participants more wary about consuming may
contain products in the future - either all ‘may contain’
products or the specific product category.
I Have you ever had a reaction?
P Yes, once, with one that said “May contain traces
of nuts”.
I What was that to?
P It was a type of chocolate bar from (supermarket)
and I had a reaction to it, even though it just said
“may contain”, and then I never ate anything that
said “may contain” again. (I, F, Severe)
Yeah, I suppose pasta sauces in a jar. That’s why I
said I don’t eat them, because they’ve got the warning
on, “Produced in a factory that contains nuts” or
“May contain nuts”, but they don’t list nuts in the
ingredients, so I’ve risked it, but had a really mild
reaction, so that it’s not worth the risk.
(I, F, Moderate)
Ignoring may contain labelling All three methods used
in this research provided evidence that many participants
ignored MCL in the sense that they sometimes bought
and consumed products labelled in this way. Participants
justified their decisions to consume products with MCL
in a range of ways and this was not systematically linked
to the characteristics of participants such as age, gender
or severity of allergy. Some participants thought there
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was almost no risk involved in consuming products with
a ‘may contain’ warning. For these people MCL was
equated with non-existent or imperceptible risk.
The Carrot & Coriander (soup) is going cheap, so I
think that one...that one will be a good one. I’ve had
this before, so I know that will be fine for nuts. No
suggestion that there’s any nuts in it anyway.
Obviously, it says “May contain nut traces”, but it
won’t, so...! (AS, M, Moderate)
For others the uncertainty MCL signalled was so
extensive that taking precautionary action was not war-
ranted and taking a risk was a more preferable
approach.
P “This product is made in a factory which also han-
dles nuts.” That statement has absolutely no impact
on me, because it doesn’t tell me what nuts. In a fac-
tory? Is it on the line or just the factory? It’s a comple-
tely useless statement, as far as I’m concerned.
I So what do you do when you see that statement
usually?
P I’ll just...if it’s not in the list of ingredients, I’ll just
risk it. (PCRT, F, Severe)
Other participants considered that although there
could be a contamination risk they were happy to eat
the product anyway.
I So what about (supermarket name) Cauliflower
Cheese?
P They’ve actually said “no nuts”, so at this point, I’d
be going I think I’m fine. The recipe has got no nuts.
“Ingredients - cannot guarantee nut-free... I’d eat
that.
I Okay, cool. So it’s because the recipe thing says no
nuts?
P Yeah, there’s a conscious thing there that says they
haven’t got any nuts in this recipe. There’s an off-
chance that some nuts might have crept in. There’s
an off-chance a jumbo jet could land on my head,
yeah, but... (PCRT, M Severe)
It is noteworthy that such participants accepted that
‘may contain’ did indicate that the food could indeed
contain nuts. The concept of risk, and the importance of
running a risk (however small), was prominent here.
The reasoning of other participants involved reference
to the potential consequence of having an allergic reac-
tion to nuts. One model that these participants adopted
was that they would stop consuming ‘may contain’
foods as and when they got a reaction.
The day that I eat something with that warning on
that sets me off with a reaction will be a really sad
day, because it will mean it will rule out a lot of
other stuff that I’ve [been willing] to risk, but so far,
touch wood, most things I eat, if ..., rather than being
a bag of oranges or whatever, you know, they all
have that caveat, so I just have to disregard it. It’s
like, yeah, I know that - tell me something else, kind
of thing. (I, F, Severe)
They’ll do. £1.85. These are okay. .... I’m going to keep
getting it until I get a reaction, in which case I’ll stop!
(AS, F, Severe)
An alternative model was that the likely reaction
would be minor and of an acceptable magnitude.
Yeah. Most of the time, anything that says “May have
traces of nuts”, then I...if I really want it, then I’ll have
it, and to be honest with you, you know, that is so low
that I’d need to eat a lot of it for it to make me really
sick. (I, F, Severe)
I mean, I think, really, there needs to be a test for this,
because...a simple test that they can say that it’s con-
taminant-free or so minimal... And for me as well,
because I have this slight reaction that I know I can
get away with it, I just have a really uncomfortable
day - I sometimes wonder how far it’s going to go, but
then drink plenty and it seems to go away. I know I
can risk it. (I, M, Moderate)
Interpreting ‘may contain’ labelling Participants made
sense of MCL with reference to different dimensions of
the context in which they are managing their allergy.
They judged, interpreted and made use of product
packaging information in relation to the two broad
dimensions of context described below.
Firstly MCL is interpreted against the backdrop of the
participant’s experience. Previous experience of a pro-
duct was an important arbiter of how any uncertainty
introduced by MCL was interpreted. Previous experi-
ence was trusted to ensure future safety. For one partici-
pant the ‘may contain’ warning could be safely ignored
in the light of previous - uneventful - consumption.
Regarding these, I will always look on the back. It
says “No nuts - cannot guarantee nut-free,” and I
know that’s fine because I’ve had them before. (AS,
M, Severe)
For another participant the experience of the moment,
for example being hungry and being in a rush, occasioned
a more relaxed approach and ‘may contain’ products
were consumed.
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It all comes down to how hungry you are, what a
hurry you’re in and everything else. You know, like
tonight, if I’d gone to get biscuits and I’d looked at
the first lot, and then I think, well, just got to, sod it,
I can’t, you know, I just haven’t got the time, and it
does come down to time and sometimes you just
have to grab things and run the risk, and other
times, you just think I won’t bother. I think I’m nor-
mally in the category of I won’t bother. (I. F, Severe)
Personal preferences were also important - participants
were more willing to eat foods they liked with a ‘may
contain’ label than those they did not like.
I would say, personally, if I really liked the product,
then I would take the risk and eat it. (I, F, Severe)
In this situation the immediate benefits outweighed
potential risk of consuming the food.
Secondly, beliefs about particular products or food
groups/product categories can affect the interpretation of
MCL. For example, ‘may contain’ warnings were inter-
preted as more credible and as warranting avoidance, if
they were linked to a ‘problematic product’.
I And then there’s the issue of the “May contain
nuts”. So, if something said “May contain traces of
nuts”, do you find that helpful?
P It depends on the product. If it’s something like
(product name) then it wouldn’t be an issue. If it’s a
cereal, like (product name), and it looks a bit dodgy,
then I wouldn’t entertain it.
I So does ‘may contain’ actually help you to make a
judgement then or...?
P Yes, on some products. Like (product), no, I would
automatically buy, wouldn’t be a problem, but on
something I wasn’t sure of, like these rice bars or
whatever, then I wouldn’t buy it. (PCRT, M, Severe)
This sometimes meant that the look of the product
aroused suspicion or if the participant thought it feasible
that the product could contain nuts.
In summary then, although there were circumstances
when MCL was seen as valuable, participants discounted
its veracity in several ways. Not consuming food with
MCL was considered unfeasible in the light of their ubi-
quity, and the perceived motivations of the source ren-
dered the labels untrustworthy. Labels were interpreted to
allow ostensibly weaker versions of the ‘may contain’
warning to be dismissed and the location of warnings on
implausible products was also used to justify dismissal. It
was clear that for a few, avoiding all foods with MCL was
the preferred option and that not to do so caused anxiety.
Most participants however, claimed that they did eat
foods with MCL and were prepared to run the risk at least
until they had a reaction. Previous experience was trusted
to signal future safety and present affective states and pre-
ferences also provided justification for consuming foods
with MCL.
Discussion
This study has explored the food choice decisions made
when nut allergic adults are faced with ‘may contain’ label-
ling. It is a complex picture. On the one hand many parti-
cipants did not believe that the ‘may contain’ message was
credible or desirable and ignored it when making food
choices. A small number of participants avoided all
products labelled in this way. In between there were a
range of other evaluations and actions: MCL triggered
anxiety and yet could reassure, it was linked both to trust
and distrust; it was ignored by some and yet others attrib-
uted meaning to minor nuances in the wording. These
findings did not seem to be linked to characteristics of the
participants such as the severity of their allergy.
This study has provided insights, not only into how peo-
ple reflect on MCL in the context of an interview but also
into ways in which people refer to MCL both in the con-
text of actual shopping practices when making decisions
about purchasing food and when faced with particular
products. The insights derived from the juxtaposition of 3
different qualitative methods proved of particular value in
exploring what allergic individuals actually do, rather than
simply working with a more general and decontextualised
focus on what nut allergic individuals say. The triangula-
tion of the accompanied shop data where participants
were making decisions and balancing multiple purchase
considerations in the shopping environment, with data
from the subsequent interview and product choice reason-
ing task enabled a ‘thick’ [36] and rich description of the
purchase and reasoning practices of nut allergic
consumers.
Consistent with previous studies [17,20,22] participants
valued some versions of MCL more than others. People
who are managing allergy on a day to day basis are often
and understandably sensitive to the ostensibly small and
often meaningless cues that are used in product labelling.
However, our findings indicate that the ways in which
these cues are interpreted have implications not only for
participants’ confidence in their risk assessment manage-
ment strategies but also for the actual product choices
that they make. The evidence that the wide variety of for-
mats for providing precautionary information currently
leads to nut allergic individuals choosing or rejecting
foods on the basis of minor (and meaningless) variations
in wording suggests that current guidance recommend-
ing standardised wording of ‘may contain’ type labels is
not being followed and might usefully be backed up by
legislation.
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Hefle et al [17] suggested that consumers may be
following unnecessarily restricted diets by heeding
MCLs. Certainly most participants in this study consid-
ered it to be impracticable and undesirable to do so.
There were a number of strategies which provided ‘rules
of thumb’ as to when MCL should be heeded or not.
Previous experience of consuming a product with no
adverse consequences was a major source of reassurance
that future consumption would also be uneventful [see
too 18]. On the other hand the immediate every day
demands of the moment - being hungry or in a hurry
for example - gave reasons for greater risk taking.
Adjudged characteristics of either the product or the
product provider are also a source of ‘evidence’ to allergic
consumers as to whether or not it is safe to consume
products with MCL. In common with other work in this
area [24] a common justification for completely ignoring
MCL was that it simply represented a strategy for manu-
facturers to ‘cover their backs’. On the other hand MCL
may be seen by some nut allergic consumers to provide
reassurance - especially when compared with no labelling
at all.
The qualitative data collected in this study have enabled
an approach that has sought to prioritise the perspective
of people with nut allergy and the meanings that they
ascribe to the may contain labels that they encounter on a
day to day basis in shopping environments. Whilst there is
no straight forward application of the concepts of reliabil-
ity and validity to qualitative research, we have sought to
apply appropriate criteria to the conduct and reporting of
this research: sensitivity to the setting in which nut allergic
people encounter MCL; commitment and rigour in both
the data collection and analysis, transparency and coher-
ence in the arguments articulated and the impact and
importance of these findings for policy and practice [37].
We recognise that the sample size did not allow us to sys-
tematically explore differences between sub-sets of partici-
pants in how they made sense of MCL e.g. between
different allergy severities, between those with a recent
and longstanding diagnosis of nut allergy or between those
with recent or distant reactions.
Conclusions
This study has identified a complex set of strategies that
nut allergic people may use to make food purchase deci-
sions when faced with ‘may contain’ labelling. These may
go some way to helping explain the on-going occurrence
of accidental exposures to nuts which are known to
occur [19]. Allergic individuals face difficult dilemmas: to
avoid food that is probably safe, or to eat foods with
MCL at the risk of a reaction. Of course it is not only
within the shopping environment that such dilemmas
exist - eating out in restaurants provides a further set of
challenges [38]. We did not assess the advice that
participants in this study had received from clinicians
nor is it known what advice clinicians generally give, but
existing data about community reactions [19] and aller-
gen contaminants [17] suggest that in clinical settings
patients should continue to be cautioned about the rea-
lity of potential reactions to food with cautionary labels.
If allergic individuals decide to consume such products,
they must be advised to reduce their risks by avoiding
eating in ‘high risk’ environments e.g. in remote areas or
without access to rescue medication.
It seems that from a legal perspective erring on the
side of using ‘may contain’ labels rather than not, is the
most defensible position to take [39]. However, it is vital
that food producers continue to undertake risk assess-
ment for contamination from nuts and seek to use clear
‘contains’ or ‘does not contain’ labelling wherever possi-
ble. Research is required to establish exactly what the
relationship is between cross contamination with nuts
and ‘may contain’ labelling. Finally, all those that are
responsible for providing advice to nut allergic indivi-
duals need to take into account the rich range of rea-
soning that consumers draw on to make and justify
their decisions to consume products that may contain
nuts and seek to understand the inferences that they
make from the presence or absence of ‘may contain’
labelling.
Acknowledgements and funding
Acknowledgements
We are grateful for the contributions of all the participants in this study.
Additionally we acknowledge the contribution of Konstantina Vasileiou in
preparing the final version of this paper.
Funding
This study formed part of a wider research study to investigate the ways in
which food allergic consumers make food purchasing and food
consumption decisions, which was funded by the UK Food Standards
Agency under project code T07058. The study sponsor had no role in study
design, the collection, analysis or interpretation of data. They provided
comment on a full draft of this paper.
Author details
1Department of Information Systems and Computing, Brunel University,
Uxbridge, Middlesex, UB8 3PH, UK. 2Department of Psychology, University of
Surrey, Guildford, Surrey, GU2 7XH, UK. 3Allergy Action/Anaphylaxis
Campaign, Farnborough, GU14 6SX, UK. 4School of Medicine, Division of
Infection, Inflammation and Immunity, University of Southampton, Tremora
Road, Southampton, S016 6YD, UK.
Authors’ contributions
All authors have participated in the design of the study and the preparation
of the manuscript. JB was principal investigator with primary responsibility
for the study and analysis of data and led the writing of this manuscript. JL
and KM conducted all interviews and participant tasks. KG provided allergy
dietetic expertise particularly for the PCRT. RS and MR provided expertise
regarding labelling. MHG provided advice as an allergic consumer. JSL is an
allergist and provided clinical expertise for the study design and analysis.
Competing interests
The authors declare that they have no competing interests.
Received: 14 June 2011 Accepted: 26 September 2011
Published: 26 September 2011
Barnett et al. BMC Public Health 2011, 11:734
http://www.biomedcentral.com/1471-2458/11/734
Page 8 of 9
References
1. Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA: A
voluntary registry for peanut and tree nut allergy: characteristics of the
first 5149 registrants. J Allergy Clin Immunol 2001, 108:128-132.
2. Grundy J, Matthews S, Bateman B, Dean T, Arshad S: Rising prevalence of
allergy to peanut in children: data from 2 sequential cohorts. J Allergy
Clin Immunol 2002, 110:784-789.
3. Ben-Shoshan M, Kagan RS, Alizadehfar R, Joseph L, Turnbull E, St Pierre Y,
Clarke AE: Is the prevalence of peanut allergy increasing? A 5-year
follow-up study in children in Montreal. J Allergy Clin Immunol 2009,
123:783-788.
4. Pumphrey RS: Anaphylaxis: can we tell who is at risk of a fatal reaction?
Curr Opin Allergy Clin Immunol 2004, 4:285-290.
5. Pumphrey RS, Gowland MH: Further fatal allergic reactions to food in the
United Kingdom, 1999-2006. J Allergy Clin Immunol 2007, 119:1018-1019.
6. Munoz-Furlong A, Weiss CC: Characteristics of food-allergic patients
placing them at risk of a fatal anaphylactic episode. Curr Allergy Asthma
Rep 2009, 9:57-63.
7. Clark AT, Ewan PW: Good prognosis, clinical features, and circumstances
of peanut and tree nut reactions in children treated by a specialist
allergy center. J Allergy Clin Immunol 2008, 122:286-289.
8. Cummings AJ, Knibb RC, Erlewyn-Lajeunesse M, King RM, Roberts G,
Lucas JS: Management of nut allergy influences quality of life and
anxiety in children and their mothers. Pediatr Allergy Immunol 2010,
21:586-594.
9. Cummings AJ, Knibb RC, King RM, Lucas JS: The psychosocial impact of
food allergy and food hypersensitivity in children, adolescents and their
families: a review. Allergy 2010, 65:933-945.
10. Connors M, Bisogni CA, Sobal J, Devine CM: Managing values in personal
food systems. Appetite 2001, 36:189-200.
11. Shepherd R: Resistance to changes in diet. Proc Nutr Soc 2002, 61:267-272.
12. Barnett J, Leftwich J, Muncer K, Grimshaw K, Shepherd R, Raats MM,
Gowland MH, Lucas JS: How do peanut and nut-allergic consumers use
information on the packaging to avoid allergens? Allergy 2011,
66:969-978.
13. Pieretti MM, Chung D, Pacenza R, Slotkin T, Sicherer SH: Audit of
manufactured products: use of allergen advisory labels and
identification of labeling ambiguities. J Allergy Clin Immunol 2009,
124:337-341.
14. van Hengel AJ: Declaration of allergens on the label of food products
purchased on the European market. Trends Food Sci Tech 2007, 18:96-100.
15. Chung D, Pieretti MM, Pacenza R, Slotkin T, Sicherer SH: Analysis of 1016
commercial food ingredient labels to review food allergen labeling and
consumer protection act (FALCPA) compliance, use of advisory
statements, and possible pitfalls for food-allergic consumers. J Allergy
Clin Immunol 2008, 121(Suppl 1):S183.
16. Food Standards Agency: Buying food when you have a food allergy or
intolerance London; 2009.
17. Hefle SL, Furlong TJ, Niemann L, Lemon-Mule H, Sicherer S, Taylor SL:
Consumer attitudes and risks associated with packaged foods having
advisory labeling regarding the presence of peanuts. J Allergy Clin
Immunol 2007, 120:171-176.
18. Sampson MA, Munoz-Furlong A, Sicherer SH: Risk-taking and coping
strategies of adolescents and young adults with food allergy. J Allergy
Clin Immunol 2006, 117:1440-1445.
19. Sheth SS, Waserman S, Kagan R, Alizadehfar R, Primeau M, Elliot S, St
Pierre Y, Wickett R, Joseph L, Harada L, Dufrense C, Allen M, Allen M,
Godefroy SB, Clarke AE: Role of food labels in accidental exposures in
food-allergic individuals in Canada. Ann Allergy Asthma Immunol 2010,
104:60-65.
20. Sheth SS, Waserman S, Kagan R, Alizadehfar R, Primeau M, Elliot S, St
Pierre Y, Turnbull E, Wickett R, Joseph L, Harada L, Dufresne C, Allen M,
Allen M, Godefroy S, Clarke A: Improving food labeling for the allergic
consumer. J Allergy Clin Immunol 2008, 121(Suppl 1):S183.
21. Verrill L, Choinirere CJ: Are food allergen advisory statements really
warnings? Variation in consumer preferences and consumption
decisions. J Food Prod Market 2009, 15:139-151.
22. Noimark L, Gardner J, Warner JO: Parents’ attitudes when purchasing
products for children with nut allergy: a UK perspective. Pediatr Allergy
Immunol 2009, 20:500-504.
23. Gallagher M, Worth A, Sheikh A: Clinical allergy has much to gain from
engagement with qualitative research. Allergy 2009, 64:1117-1119.
24. Akeson N, Worth A, Sheikh A: The psychological impact of anaphylaxis on
young people and their parents. Clin Exp Allergy 2007, 37:1213-1220.
25. Fenton NE, Elliot SJ: Consumers response to precautionary statements on
food labels. Canada: Health Canada.
26. Hourihane JO, Kilburn SA, Dean P, Warner JO: Clinical characteristics of
peanut allergy. Clin Exp Allergy 1997, 27:634-639.
27. Moran-Ellis J, Alexander VD, Cronin A, Dickinson M, Fielding J, Sleney J,
Thomas H: Triangulation and integration: processes, claims and
implications. Qualitative Research 2006, 6:45-59.
28. Ericsson K, Simon H: Protocol Analysis: Verbal reports as data (Rev. Ed.)
Cambridge, MA: MIT Press; 1993.
29. Payne J: Thinking aloud: insights into information processing. Psychol Sci
1994, 5:241-248.
30. Cornelisse-Vermaat JR, Voordouw J, Yiakoumaki V, Theodoridis G, Frewer LJ:
Food-allergic consumers’ labelling preferences: a cross cultural
comparison. Eur J Public Health 2008, 18:115-120.
31. Higginson CS, Kirk TR, Rayner MJ, Draper S: How do consumers use
nutrition label information? Nutrition & Food Science 2002, 32:145-152.
32. Reicks M, Smith C, Henry H, Reimer K, Atwell J, Thomas R: Use of think
aloud method to examine fruit and vegetable purchasing behaviors
among low-income African American women. J Nutr Educ Behav 2003,
35:154-160.
33. Barnett J, Leftwich J, Muncer K, Raats M, Shepherd R, Ogden J, Lucas JS,
Grimshaw K: Understanding the food choice reasoning of nut allergic
consumers: Final Report Food Standards Agency; 2011 [http://www.
foodbase.org.uk/results.php?f_category_id=&f_report_id=682].
34. NVivo qualitative data analysis software [computer program]: Version 8 QSR
International PTY Ltd 2008.
35. Braun V, Clarke V: Using thematic analysis in psychology. Qualitative
Research in Psychology 2006, 3:77-101.
36. Geertz C: Thick description: toward an interpretive theory of culture. In
The interpretations of Cultures. Edited by: Geertz C. New York: Basic Books;
1973:3-30.
37. Yardley L: Dilemmas in qualitative health research. Psychol Health 2000,
15:215-228.
38. Leftwich J, Barnett J, Muncer K, Shepherd R, Raats MM, Gowland MH,
Lucas JS: The challenges for nut-allergic consumers of eating out. Clin
Exp Allergy 2011, 41:243-249.
39. Pape S: May contain labelling: Adequate consumer warning or
unnecessarily defensive manufacturer behaviour? J Consum Policy 2009,
32:165-188.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2458/11/734/prepub
doi:10.1186/1471-2458-11-734
Cite this article as: Barnett et al.: Using ‘may contain’ labelling to inform
food choice: a qualitative study of nut allergic consumers. BMC Public
Health 2011 11:734.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Barnett et al. BMC Public Health 2011, 11:734
http://www.biomedcentral.com/1471-2458/11/734
Page 9 of 9
